PremiumCompany AnnouncementsBioxyne Limited Announces Investor Webinar for March 2025 Bioxyne Limited Reports Strong Financial Recovery for 2024 Half-Year Bioxyne Limited Achieves Record Q2 Results, Plans Expansion into Europe PremiumCompany AnnouncementsBioxyne Limited Announces Cessation of Securities Bioxyne Limited Addresses ASX Price Query Compliance Bioxyne Limited Announces AGM Success with Key Resolutions PremiumCompany AnnouncementsBioxyne Limited Issues New Employee Incentive Securities Bioxyne Limited Announces 2024 Annual General Meeting Bioxyne Limited Eyes Leadership in Novel Medicines